Seeing Is Believing
HAE is currently covered by 7 analysts with an average price target of $106.53. This is a potential upside of $21.1 (24.7%) from yesterday's end of day stock price of $85.43.
Haemonetics's activity chart (see below) currently has 136 price targets and 113 ratings on display. The stock rating distribution of HAE is 36% HOLD and 64% BUY.
Analysts average stock forecasts to be materialized ratio is 73.86% with an average time for these price targets to be met of 302.36 days.
Highest price target for HAE is $125, Lowest price target is $85, average price target is $106.53.
Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 15-Nov-2024. First documented stock forecast 18-Nov-2009.
Currently out of the existing stock ratings of HAE, 9 are a HOLD (36%), 16 are a BUY (64%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$112
$22.53 (25.18%)
$112
6 days ago
(15-Nov-2024)
3/7 (42.86%)
$22.53 (25.18%)
358
Buy
$120
$30.53 (34.12%)
$100
13 days ago
(08-Nov-2024)
6/8 (75%)
$34.73 (40.73%)
163
Buy
$108
$18.53 (20.71%)
$107
1 months 29 days ago
(23-Sep-2024)
20/30 (66.67%)
$31.62 (41.40%)
299
Hold
$85
$-4.47 (-5.00%)
$90
2 months 30 days ago
(22-Aug-2024)
11/11 (100%)
$9.5 (12.58%)
168
Buy
$125
$35.53 (39.71%)
$125
3 months 8 days ago
(13-Aug-2024)
6/14 (42.86%)
$50.73 (68.30%)
237
What is HAE (Haemonetics) average time for price targets to be met?
Which analyst has the current highest performing score on HAE (Haemonetics) with a proven track record?
Which analyst has the most public recommendations on HAE (Haemonetics)?
Which analyst is the currently most bullish on HAE (Haemonetics)?
Which analyst is the currently most reserved on HAE (Haemonetics)?